Menu Search
Equities

InventisBio Co Ltd

688382:SHH

InventisBio Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)7.50
  • Today's Change-0.17 / -2.22%
  • Shares traded3.77m
  • 1 Year change-44.65%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year InventisBio Co Ltd grew revenues -- from 0.00 to 185.53m while net income improved from a loss of 483.49m to a smaller loss of 283.98m.
Gross margin94.63%
Net profit margin-274.46%
Operating margin-274.46%
Return on assets-15.82%
Return on equity-16.96%
Return on investment-16.90%
More ▼

Cash flow in CNYView more

In 2023, cash reserves at InventisBio Co Ltd fell by 1.02bn. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 307.75m for operations while cash used for investing totalled 699.33m.
Cash flow per share--
Price/Cash flow per share--
Book value per share3.15
Tangible book value per share3.15
More ▼

Balance sheet in CNYView more

InventisBio Co Ltd appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio12.74
Quick ratio--
Total debt/total equity0.0038
Total debt/total capital0.0038
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.